/
NURPF
$9.27+$0.58 (+6.67%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$7.70 – $14.80
22% from low
Exchange
OTC Link
OS
Price (6 mo)
Loading chart…
Change+$6.55
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.0M | $495.0K | $717.0K | $3.2M | $14.6M | $231.9M | $216.8M | $64.6M |
| Cost of revenue | $6.1M | $4.0K | $6.0K | $8.0K | $10.0K | $26.8M | $33.0M | $23.0K |
| Gross profit | $7.9M | $491.0K | $711.0K | $3.2M | $14.5M | $205.2M | $183.9M | $64.6M |
| Gross margin | 56.4% | 99.2% | 99.2% | 99.7% | 99.9% | 88.5% | 84.8% | 100.0% |
| R&D | $6.1M | $9.9M | $7.8M | $9.5M | $12.7M | $26.8M | $33.0M | $36.4M |
| Operating income | $5.8M | −$11.6M | −$16.6M | −$17.7M | −$1.6M | $172.5M | $146.2M | $22.0M |
| EBITDA | $5.4M | −$11.3M | −$8.8M | −$8.2M | −$722.0K | $199.3M | $179.2M | $22.0M |
| Net income | $3.1M | −$10.8M | −$9.2M | −$7.8M | $184.0K | $157.1M | $142.0M | $30.4M |
| Net margin | 22.0% | -2185.1% | -1282.1% | -243.8% | 1.3% | 67.7% | 65.5% | 47.1% |
| EPS (diluted) | 0.03 | -0.11 | -0.09 | -0.07 | 0.00 | 1.20 | 1.09 | 0.24 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $99M | $0.18 | $0.09–$0.26 | 2 |
| 2027 | $161M | $0.37 | $0.19–$0.53 | 2 |
| 2028 | $253M | $1.18 | $0.59–$1.68 | 3 |
| 2029 | $1.2B | $5.49 | $2.74–$7.82 | 2 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.59
Price
$9.27
Implied downside
-94%
Peer comparison
NEUREN PHARMS LTD ORD
NEUREN PHARMS LTD ORD
Held by traders on TradeandTell
No one on the platform currently holds NURPF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in NURPF as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded NURPF yet.